RELX NV provides information and analytics for professional and business customers across industries worldwide. Segments The company operates in four major market segments: Scientific, Technical & Medical; Risk & Business Analytics; Legal; and Exhibitions. Scientific, Technical & Medical segment This segment provides information, analytics and tools to help customers make decisions that improve scientific and healthcare outcomes. The company provides scientific, technical and medical information serving scientists, health professionals and students worldwide. The company serves customers in approximately 170 countries. The company serves the needs of scientific, technical and medical markets by organizing the review, editing and disseminating of primary research, reference and education content, as well as by providing a range of database and decision tools. The company’s customers are scientists, academic institutions, educators, research leaders and administrators, medical researchers, doctors, nurses, allied health professionals and students, as well as hospitals, research institutions, health insurers, managed healthcare organizations, research-intensive corporations and governments. In 2015, the company launched 73 new subscription and author-pays journals, including a new open access cross-discipline title, Heliyon, and expanded the Cell Press collection, adding titles, such as Trends in Cancer and Cell Systems. The company also operates in scientific, technical and medical reference markets worldwide, providing authoritative professional reference content. Primary titles include works, such as Gray’s Anatomy, Nelson’s Pediatrics and Netter’s Atlas of Human Anatomy. The company’s primary clinical reference platform, ClinicalKey, provides physicians with access to the company and third-party reference and evidence-based medical content in a single integrated site. ClinicalKey is accessed by approximately 3,500 institutions. In medical education, the company serves students of medicine, nursing and allied health professions through print and electronic books, as well as electronic solutions. HESI, an online testing and remediation solution designed to help students of nursing and allied health professions, conducted approximately 750,000 tests in 2015. The company’s products provide a range of tools and solutions for professionals in the scientific, technical and medical fields. Customers include academic and corporate researchers, research administrators and healthcare professionals. For academic and corporate researchers, major products include Scopus, Reaxys and Knovel. Scopus, the major abstract and citation database of peer-reviewed literature with approximately 60m records from approximately 21,000 journals and 5,000 international publishers, allows researchers to track, analyze and visualize the world’s research output. Reaxys supports the early stages of drug development in the pharmaceutical industry, exploratory chemistry research in academia, and product development in industries, such as chemicals and oil and gas. Knovel is a decision support tool for engineers that helps them to select the right materials, a mission-critical use case in product development across chemicals, oil and gas, and other engineering-focused industries. The company serves academic and government research administrators through its Elsevier Research Intelligence suite of products. Leveraging bibliometric data from Scopus and other data types, SciVal is a decision tool that helps institutions to establish, execute and evaluate research strategies. Pure is a research information management system, which enables evidence-based research management decisions, promotes collaboration, simplifies administration and optimises impact. The company’s Analytical Services team provides unbiased analysis on research performance by combining data sources with technical and research metrics expertise. SciVal Funding assists researchers and institutions in identifying grants that are most relevant in their research areas. For healthcare professionals, the company develops products to deliver patient-speci
relx nv (REN:EN Amsterdam)
Amsterdam, 1043 NX
Phone: 31 20 485 2222
Fax: 31 20 485 2032www.r-e.com
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content.
|No competitor information is available for REN.|
|View Industry Companies|
Sponsored Financial Commentaries
To contact RELX NV, please visit www.r-e.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.